Hydroxyzine Does Not Cause False-Positive Plasma Free Metanephrines
Hydroxyzine is not known to interfere with plasma free fractionated metanephrines testing and is not listed among medications that cause false-positive results for pheochromocytoma/paraganglioma screening.
Evidence-Based Analysis
What Actually Causes False-Positives
The Endocrine Society guidelines 1 specifically identify medications that interfere with metanephrine testing, including:
- Tricyclic antidepressants (which cause significant interference)
- Drugs that directly interfere with measurement methods (acetaminophen, mesalamine, sulfasalazine)
- Medications affecting catecholamine disposition
Recent high-quality research 2 confirms that norepinephrine reuptake blockers (tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors) are the primary culprits, increasing:
- Plasma normetanephrine by 40% (false-positive rate rising from 4.8% to 23.0%)
- Methoxytyramine by 127% (false-positive rate rising from 0.9% to 28.6%)
Additional research 3 identifies that α1-blockers, antidepressants, and antipsychotics can affect urinary fractionated metanephrines, but notably hydroxyzine is not mentioned.
Hydroxyzine's Known Interferences
The FDA drug label 4 for hydroxyzine does not mention any interference with catecholamine or metanephrine testing. The documented interferences for hydroxyzine are limited to:
- Tricyclic antidepressant immunoassays (FPIA method) - confirmed by research 5
- CNS depressant potentiation
- QT prolongation risk
Research 5 specifically demonstrates that hydroxyzine causes false-positive TCA immunoassays but explicitly states it does not interfere with other assays tested.
Clinical Implications
When to Suspect True Interference
If you encounter an elevated plasma metanephrine result in a patient on hydroxyzine:
- Do not attribute it to hydroxyzine - look for other causes
- Review for actual interfering medications (tricyclics, SNRIs, α1-blockers)
- Ensure proper collection technique (supine position for 30 minutes) 1
- Consider physiological stress, laboratory error, or actual tumor
Common Pitfalls to Avoid
- Do not discontinue hydroxyzine based on elevated metanephrines - it's not the cause
- Recognize that hydroxyzine's cross-reactivity is limited to TCA immunoassays, not catecholamine metabolite testing
- Remember that false-positive drug screens (amphetamines, TCAs) are different from false-positive biochemical tumor markers
The evidence clearly distinguishes between drugs causing false-positive drug screens versus those affecting metanephrine measurements - hydroxyzine falls only in the former category 6, 7.